A recent study found permanent pacemaker infection (PPMI) in 2.09% patients, with infections more prevalent in devices ...

FDA agreed that data from the Phase 2a diSArm study support advancement of AP-SA02 to a Phase 3study First bacteriophage company to advance a clinical candidate to ...

Researchers have developed a sunlight-activated nanospray that can rapidly kill drug-resistant bacteria, stop bleeding and relieve pain, significantly accelerating the healing of infected diabetic ...

Artificial intelligence is revolutionizing antibiotic discovery, potentially tackling antibiotic-resistant bacteria and ...

A 17-month-long study at the Cambria County Prison has determined that the air filtration system installed by Germ Solution ...

A Missouri couple has been charged with child endangerment after they allegedly allowed a child suffer with a serious staph ...

Armata Pharmaceuticals, Inc. ("Armata" or the "Company"), a late clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the ...

Select gut bacteria protect mice against post-influenza virus secondary bacterial pneumonia, according to a study published ...

Genes that protect the body against infection during youth can do harm in old age, according to a study 1 in mice. The ...

The use of nanoparticles to improve feed efficiency and poultry health has significant potential to reduce the spread of ...

Houttuynia cordata extract, a traditional medicinal plant-derived product, is emerging as a potential alternative to ...